The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly
- PMID: 1487621
The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly
Abstract
Fifteen healthy male volunteers aged over 60 years received acute and repeated doses of paroxetine 20 mg or placebo, and acute doses of lorazepam 1 mg (as a positive internal control) with or without alcohol (0.6 g/kg of body weight) administered openly in a double blind balanced crossover study in which each subject acted as his own control. Psychomotor performance and cognitive function were assessed using a test battery which included critical flicker fusion, choice reaction time, compensatory tracking, Stroop and memory scanning tests. Subjective ratings of mood and sleep were recorded using line analogue rating scales. The pattern of results indicated that paroxetine had little or no effect on most of the test variables, and in some instances (critical flicker fusion thresholds) improved information processing ability. This was in marked contrast to the lorazepam verum which produced sedation and disruption of performance. Paroxetine had a slight antagonistic effect on alcohol induced sedation whereas impairment of performance with lorazepam was potentiated by co-administration of alcohol. The low behavioural toxicity of paroxetine in elderly volunteers has important implications for the pharmacotherapy of depression.
Similar articles
-
The effects of alcohol and other drugs on psychomotor performance and cognitive function.Alcohol Alcohol. 1991;26(1):71-9. Alcohol Alcohol. 1991. PMID: 1854375 Clinical Trial.
-
The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.Curr Med Res Opin. 2001;17(4):273-81. Curr Med Res Opin. 2001. PMID: 11922401 Clinical Trial.
-
Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.Hum Psychopharmacol. 2006 Jan;21(1):13-26. doi: 10.1002/hup.741. Hum Psychopharmacol. 2006. PMID: 16389668 Clinical Trial.
-
The effects of sertraline on psychomotor performance in elderly volunteers.J Clin Psychiatry. 1990 Dec;51 Suppl B:34-6. J Clin Psychiatry. 1990. PMID: 2258380 Review.
-
A review of the psychomotor effects of paroxetine.Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:65-7. doi: 10.1097/00004850-199206004-00012. Int Clin Psychopharmacol. 1992. PMID: 1431014 Review.
Cited by
-
Pharmacokinetic interactions between alcohol and other drugs.Clin Pharmacokinet. 1997 Aug;33(2):79-90. doi: 10.2165/00003088-199733020-00001. Clin Pharmacokinet. 1997. PMID: 9260032 Review.
-
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.Drugs. 1998 Jan;55(1):85-120. doi: 10.2165/00003495-199855010-00007. Drugs. 1998. PMID: 9463792 Review.
-
Three weeks of SSRI administration enhances the visual perceptual threshold - a randomized placebo-controlled study.Psychopharmacology (Berl). 2019 Jun;236(6):1759-1769. doi: 10.1007/s00213-018-5158-3. Epub 2019 Jan 8. Psychopharmacology (Berl). 2019. PMID: 30623228 Clinical Trial.
-
The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review.J Psychopharmacol. 2022 May;36(5):578-593. doi: 10.1177/02698811221080462. Epub 2022 Apr 29. J Psychopharmacol. 2022. PMID: 35486412 Free PMC article.
-
Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.Drugs Aging. 1993 May-Jun;3(3):278-99. doi: 10.2165/00002512-199303030-00008. Drugs Aging. 1993. PMID: 8324301 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources